<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Defects in glycosylation of alpha-dystroglycan are associated with several forms of <z:hpo ids='HP_0003560'>muscular dystrophies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations in POMT2 gene have been identified in patients with <z:hpo ids='HP_0003741'>congenital muscular dystrophy</z:hpo> and brain involvement, either characterized by a Walker-Warburg/muscle-eye-brain phenotype, or by <z:hpo ids='HP_0000252'>microcephaly</z:hpo>, <z:hpo ids='HP_0001249'>mental retardation</z:hpo>, and <z:hpo ids='HP_0001321'>cerebellar hypoplasia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We identified a POMT2 homozygous missense mutation in a girl with a mild <z:hpo ids='HP_0006785'>limb-girdle muscular dystrophy</z:hpo> (LGMD) phenotype, marked <z:hpo ids='HP_0003236'>elevated serum creatine kinase</z:hpo> levels, and absence of brain involvement </plain></SENT>
<SENT sid="3" pm="."><plain>Muscle biopsy revealed myopathic and inflammatory changes and severe alpha-dystroglycan reduction </plain></SENT>
<SENT sid="4" pm="."><plain>In view of the remarkable mild clinical picture, we propose to designate this phenotype as LGMD2N </plain></SENT>
</text></document>